Sponsors Want Answers On Consequences Of Missing US FDA Trial Diversity Goals

diversity
Sponsors are hoping clinical trial diversity guidance updates will include more clarity on FDA actions when enrollment goals are missed. • Source: Shutterstock

More from Diversity & Inclusion

More from Clinical Trials